← Back

$ Value

$0

Shares

28,576

Price

$0

Filed

Aug 29

Insider

Name

Thomas John

Title

CIK

0001939103

Roles

Director

Transaction Details

Transaction Date

2025-08-27

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

28,576

Footnotes

Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders. | The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Filing Info

Accession No.

0001641172-25-026003

Form Type

4

Issuer CIK

0001231457

Thomas John's History

Date Ticker Type Value
2026-03-02 GNLX $29K
2025-12-01 GNLX $50K
2025-08-27 GNLX A $0
2025-08-27 GNLX A $0
2025-06-06 GNLX G $0

Other Insiders at GNLX (90d)

Insider Bought Sold Last
Yu Yong / Cappello Joseph
SVP, Clinical Development
$2K 2026-03-24
Zindrick Thomas
President and CEO
$9K 2026-03-24
Thomas John $29K 2026-03-02
Smalling Ralph
Head of Regulatory
$1K 2026-03-25